(Press-News.org) Contact: Vanessa Solomon
solomon@wehi.edu.au
61-393-452-971
Walter and Eliza Hall Institute
Rachel Steinhardt
rsteinhardt@licr.org
212-450-1582
Ludwig Institute for Cancer Research
'Dark-horse' molecule is a potential new anti-cancer target
Australian researchers have identified a molecule called interleukin-11 as a potential new target for anti-cancer therapies.
Until now, the importance of interleukin-11 in cancer development has been underestimated, but researchers have recently identified this molecule as a 'dark horse' for the development of cancer. Their discovery suggests blocking interleukin-11 signalling could ultimately provide an exciting new approach to the treatment of bowel and stomach cancer, which are two of the most common cancers worldwide.
When a tumour develops, the normal (non-cancerous) tissues around it can become inflamed, and produce many different molecules, including the two related proteins interleukin-11 and interleukin-6. These hormone-like signalling molecules, referred to as cytokines, are thought to promote the growth and spread of cancer cells, but interleukin-11 was thought to have only a minor, if any, role during cancer development.
However Dr Tracy Putoczki and Associate Professor Matthias Ernst from the Walter and Eliza Hall Institute's Cell Signalling and Cell Death division have now shown that interleukin-11 is one of the most important cytokines that stimulate the growth and spread of cancers. Working with scientists at the Melbourne-based pharmaceutical company CSL Ltd, they discovered that blocking interleukin-11 in models of stomach and bowel cancer stopped tumour growth and could lead to tumour shrinkage, making this cytokine a promising potential new target for treating many types of solid cancers.
Dr Putoczki and Associate Professor Ernst made most of their discoveries while working at the Melbourne-Parkville Branch of the Ludwig Institute for Cancer Research, where Associate Professor Ernst is an institute member. Their findings are published online today in the journal Cancer Cell.
Dr Putoczki said the team was stunned to discover that interleukin-11 was much more potent in promoting cancer development than interleukin-6. "When considering which cytokines drive cancer development, interleukin-6 has always been in the spotlight," she said. "Despite being very similar to interleukin-6, interleukin-11 has often been overlooked by cancer researchers. Our new research now shows that it might in fact be very important."
Associate Professor Ernst said the team had begun to explore how the discovery could be applied to potential new anti-cancer therapies. "Treating cancers with agents that block cytokine signalling is an exciting new approach that potentially has advantages over current treatment strategies," he said. "Drugs that block the action of cytokines have previously been developed for both inflammatory disease and cancer and, in the case of interleukin-11, our work does not suggest the likelihood of undesirable side-effects. Moreover, agents that inhibit interleukin-6 signalling are already in clinical trials for ovarian, kidney, prostate and breast cancer. Our discovery paves the way for trials of agents that stifle interleukin-11."
Dr Andrew Nash, senior vice president for research at CSL, agreed that the research had identified a potentially important role for interleukin-11 in stomach and bowel cancer. "We have developed a number of potential drug candidates that target the interleukin-11 receptor and this data provides preclinical evidence supporting progression into clinical studies," Dr Nash said.
INFORMATION:
The research was supported by the Ludwig Insitute of Cancer Research, CSL Ltd, the Australian National Health and Medical Research Council, Cancer Australia, Cure Cancer Australia, German Cancer Aid, and the Victorian Government.
'Dark-horse' molecule is a potential new anti-cancer target
2013-08-12
ELSE PRESS RELEASES FROM THIS DATE:
Aggressive breast cancers may be sensitive to drugs clogging their waste disposal
2013-08-12
Boston, Mass., August 12, 2013 – In a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine reports "triple-negative" breast cancers may be vulnerable to drugs that attack the proteasome. This cellular structure acts as the cell's waste disposal, breaking down damaged or unneeded proteins.
These cancers, which lack the three major therapeutic markers for breast cancer—the estrogen, progesterone and HER2 receptors—are very aggressive and difficult to treat. They mostly affect younger women ...
Young or old, song sparrows experience climate change differently from each other
2013-08-12
What's good for adults is not always best for the young, and vice versa. At least that is the case with song sparrows and how they experience the effects of climate change, according to two recent studies by scientists at the University of California, Davis, and Point Blue Conservation Science.
Both studies show the importance of considering the various stages and ages of individuals in a species -- from babies to juveniles to adults -- to best predict not only how climate change could affect a species as a whole, but also why.
"To learn how climate change is expected ...
Singapore scientists unravel cancers linked to herbal remedies
2013-08-12
Singapore, 12 August 2013 – A team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, and Taiwan's Chang Gung Memorial Hospital, LinKou, have made a breakthrough in understanding the cancer-promoting action of Aristolochic Acid (AA), a natural product of Aristolochia plants traditionally used in some Asian herbal remedies for weight loss and slimming. Using advanced DNA sequencing technologies, the team, led by Professors Teh Bin Tean, See-Tong Pang, Patrick Tan and Steve Rozen discovered that AA is the most potent carcinogen ...
Largest study of epilepsy patients ever conducted reveals new and surprising genetic risk factors
2013-08-12
NEW YORK, August 11 – Neurologists and epilepsy researchers from NYU Langone Medical Center were among scientists who have 329 random genetic mutations associated with two of the most severe forms of epilepsy, according to a paper published today in Nature. Though well-known that many forms of epilepsy are strongly influenced by genetics, there has been relatively little progress in identifying the genetic differences that contribute to most forms of epilepsy. This study sheds light on why some with an elevated risk for epilepsy never get the disease and why certain medications ...
School lunch and TV time linked with childhood obesity
2013-08-12
The findings by the University of Michigan Frankel Cardiovascular Center will be published in the September issue of Pediatrics.
While some habits were the same for all overweight and obese children, the study found some gender differences in the habits influencing body weight.
Data from 1,714 sixth grade students enrolled in Project Healthy Schools showed girls who drank two servings of milk each day were less likely to be obese, and boys who played on a sports team were also at a healthier weight.
"Additional work is needed to help us understand the beneficial impact ...
Physicists investigate formation of defects during phase transitions in crystals of ions
2013-08-12
Research groups at Johannes Gutenberg University Mainz (JGU) and the Physical-Technical Federal Institute (PTB) in Braunschweig, working in collaboration with scientists at the University of Ulm and The Hebrew University of Jerusalem, have been investigating the formation of defects occurring when a Coulomb crystal of ions is driven through a second-order phase transition. For this purpose, they compressed one-dimensional linear chains of ions at high speeds to form a two-dimensional zigzag structure with a form similar to that of an accordion. This process can lead to ...
Scientists have found new evidence to show how early humans migrated into Europe
2013-08-12
Humans originated in Africa. But what route did they take as they began to disperse around the world 60,000 years ago? A new professor at the University of Huddersfield has played a key role in finding the answer to one of the most fundamental questions in the history of mankind.
Professor Richards, who moved to Huddersfield from the University of Leeds, is a pioneer in the field -- one of just two professors of archaeogenetics in the world. He uses DNA evidence to study human origins, comparing data from modern samples across the world and occasionally to that which ...
Young beer-drinkers binge-drink more frequently
2013-08-12
Just under a third of young Swiss men prefer beer when they drink alcohol, taking in at least two thirds of their alcohol consumption in the form of the beverage. Far fewer (around five percent) prefer wine. Is there an association between the preference for particular alcoholic beverages and a riskier approach to alcohol or other substances? This is what researchers from the Institute of Social and Preventive Medicine at the University of Zurich and Lausanne University Hospital wanted to find out by conducting a survey of around 5,400 men with an average age of 20 as part ...
Scientist names new fly species after the professor who has supported his work
2013-08-12
A Professor from The University of Manchester has had his name immortalised as a new species of fly.
Professor Richard Preziosi, from the Faculty of Life Sciences, said he was delighted with the unusual tribute from researcher Dr. Dave Penney.
It follows his continued support of Dr. Penney's unfunded research into amber rocks which he has been investigating for around 20 years.
Dr. Penney discovered the new species of fly, which he has named Proceroplatus preziosii, on the Caribbean island of Hispaniola, after finding a fossil in 16 million-year-old amber from the ...
Sense of smell: The nose and the brain make quite a team... in disconnection
2013-08-12
Alan Carleton's team from the Neuroscience Department at the University of Geneva (UNIGE) Faculty of Medicine has just shown that the representation of an odor evolves after the first breath, and that an olfactory retentivity persists at the central level. The phenomenon is comparable to what occurs in other sensory systems, such as vision or hearing. These movements undoubtedly enable the identification of new odors in complex environments or participate in the process of odor memorization. This research is the subject of a publication in the latest online edition of the ...